Infection of human retinal pigment epithelial cells with influenza a viruses

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 11, 2009, Pages 5419-5425

  Michaelis, Martin ^a   Geiler, Janina ^a   Klassert, Denise ^a   Doerr, Hans Wilhelm ^a   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BETA1A INTERFERON; CASPASE 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; IC 50; IMMUNOHISTOCHEMISTRY; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RETINA DISEASE; SEASONAL INFLUENZA; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CHEMOKINES; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INTERFERON TYPE I; INTERFERON-GAMMA; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; VIRUS REPLICATION;

EID: 73449143777     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3752     Document Type: Article

References (49)

1. Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Med Microbiol Immunol. 2007;196:181-190.
2. Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza a (H5N1). Part II: clues to pathogenicity and pathology. Med Microbiol Immunol. 2007;196:191-201.
3. Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part III: Antiviral therapy. Med Microbiol Immunol. 2007; 196:203-212.
4. Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Med Microbiol Immunol. 2007;196:213-225.
5. Maines TR, Szretter KJ, Perrone L et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev. 2008;225:68-84.
6. Michaelis M, Doerr HW, Cinatl J Jr. Of chickens and men: avian influenza in humans. Curr Mol Med. 2009;9:131-151.
7. Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37: 313-352.
8. Sandrock C, Kelly T. Clinical review: update of avian influenza A infections in humans. Crit Care. 2007;11:209.
9. de Wit E, Kawaoka Y, de Jong MD, Fouchier RA. Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine. 2008;26:D54-D58.
10. Scholz M, Doerr HW, Cinatl J. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol. 2003;11:171-178.
11. Weinberg RJ, Nerney JJ. Bilateral submacular hemorrhages associated with an influenza syndrome. Ann Ophthalmol. 1983;15:710-712.
12. Kovács B. Alteration of the blood-retina barriers in cases of viral retinitis. Int Ophthalmol. 1985;8:159-166.
13. Rabon RJ, Louis GJ, Zegarra H, Gutman FA. Acute bilateral posterior angiopathy with influenza A viral infection. Am J Ophthalmol. 1987;103:289-293.
14. Fukami S, Wakakura M, Inouye J. Influenza retinitis: association with influenza encephalitis. Ophthalmologica. 2005;219:119-121.
15. Fujimoto S, Kobayashi M, Uemura O, et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 1998;352:873-875.
16. Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol. 1999; 58:420-425.
17. de Jong MD. H5N1 transmission and disease: observations from the frontlines. Pediatr Infect Dis J. 2008;27:S54-S56.
18. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol. 2008;172:1155-1170.
19. Zhang Z, Zhang J, Huang K, et al. Systemic infection of avian influenza A virus H5N1 subtype in human. Hum Pathol. 2009; 40(5):735-739.
20. Kalthoff D, Breithaupt A, Teifke JP, et al. Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg Infect Dis. 2008;14:1267-1270.
21. Cinatl J Jr, Blaheta R, Bittoova M, et al. Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J Immunol. 2000; 165:4405-4413.
22. Cinatl J Jr, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW. Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol. 2001;167:1900-1908.
23. Cinatl J Jr, Michaelis M, Fleckenstein C, et al. West Nile virus infection induces interferon signalling in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47:645-651.
24. Michaelis M, Suhan T, Reinisch A, et al. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest Ophthalmol Vis Sci. 2005;46:3451-3457.
25. Michaelis M, Kleinschmidt MC, Doerr HW, Cinatl J Jr. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother. 2007;60:981-986.
26. Schmidt-Chanasit J, Bleymehl K, Rabenau HF, Ulrich RG, Cinatl J Jr, Doerr HW. In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J Clin Microbiol. 2008;46:2122-2124.
27. Bunt-Milam AH, Saari JC. Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina. J Cell Biol. 1983;97: 703-712.
28. Uiprasertkul M, Kitphati R, Puthavathana P, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis. 2007;13:708-712.
29. Lam WY, Tang JW, Yeung AC, Chiu LC, Sung JJ, Chan PK. Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol. 2008;82:2741-2751.
30. Wang G, Zhang J, Li W, et al. Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses. Cell Mol Immunol. 2008;5:113-120.
31. Zheng BJ, Chan KW, Lin YP, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A. 2008;105:8091-8096.
32. Daidoji T, Koma T, Du A, et al. H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol. 2008;82:11294-11307.
33. Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res. 2005;68:10-17.
34. De Clercq E, Neyts J. Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention. Trends Pharmacol Sci. 2007;28:280-285.
35. Thitithanyanont A, Engering A, Ekchariyawat P, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol. 2007;179:5220-5227.
36. Kugel D, Kochs G, Obojes K, et al. Intranasal administration of interferon-alpha reduces seasonal influenza a virus morbidity in ferrets. J Virol. 2009;83(8):3843-3851.
37. Van Hoeven N, Belser JA, Szretter KJ, et al. Pathogenesis of the 1918 pandemic and H5N1 influenza virus infection in a guinea pig model: the antiviral potential of exogenous alpha-interferon to reduce virus shedding. J Virol. 2009;83(7):2851-2861.
38. Wurzer WJ, Planz O, Ehrhardt C, et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 2003; 22:2717-2728.
39. Mazur I, Wurzer WJ, Ehrhardt C, et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol. 2007;9:1683-1694.
40. Mersich SE, Baumeister EG, Riva D, et al. Influenza circulating strains in Argentina exhibit differential induction of cytotoxicity and caspase-3 in vitro. J Clin Virol. 2004;31:134-139.
41. Brydon EW, Morris SJ, Sweet C. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev. 2005;29:837-850.
42. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med. 2002;8:950-954.
43. Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res. 2004;103:107-113.
44. Tumpey TM, Szretter KJ, Van Hoeven N, et al. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol. 2007;81:10818-10821.
45. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood. 2006;107:2613-2618.
46. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005;6:135.
47. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet. 2002;360:1831-1837.
48. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis. 2006;194:61-70.
49. Deng R, Lu M, Korteweg C, et al. Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J Pathol. 2008;216:328-336.